2016 updated EULAR evidence-based recommendations for the management of gout
Pascal Richette(Inserm), Michael Doherty(University of Nottingham), Eliseo Pascual(Hospital General Universitario de Alicante Doctor Balmis), В Г Барскова, Fabio Becce(University of Lausanne), Johann Castañeda-Sanabria(Inserm), M. Coyfish, S. Guillo(Inserm), Tim Jansen(Radboud University Nijmegen), M. Janssen(Radboud University Nijmegen), Frédéric Lioté(Inserm), Christian Mallen(Keele University), G. Nuki(University of Edinburgh), Fernando Pérez-Ruiz(Hospital de Cruces), José Bravo Pimentão(Instituto do Coração), Leonardo Punzi(University of Padua), T Pywell, Alexander So(University of Lausanne), A.-K. Tausche(Technische Universität Dresden), Till Uhlig(Diakonhjemmet Hospital), Jakub Závada(Charles University), Weiya Zhang(University of Nottingham), Florence Tubach(Inserm), Thomas Bardin(Inserm)
Cited by 1,661Open Access
Abstract
Related Papers
Efficacy of Febuxostat for Slowing the GFR Decline in Patients With CKD and Asymptomatic Hyperuricemia: A 6-Month, Double-Blind, Randomized, Placebo-Controlled Trial
Dipankar Sircar, Soumya Chatterjee, Rajesh Waikhom et al.|American Journal of Kidney Diseases|2015|320